According to the Zhitong Finance App, Clover Bio-B (02197.HK) announced results for the six months ended June 30, 2026. The group achieved revenue of 179,000 yuan, a year-on-year decrease of 94.5%; other revenue and revenue of 1,112 billion yuan, an increase of 6200.94%; profit attributable to owners of the parent company was 955 million yuan, turning a year-on-year loss into a profit; basic profit per share was 0.75 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.